You are viewing an incomplete version of our website. Please click to reload the website as full version.

anti-PML-RARA Regulated Adaptor Molecule 1 (PRAM1) Antibodies

The protein encoded by PRAM1 is similar to FYN binding protein (FYB\\/SLAP-130), an adaptor protein involved in T cell receptor mediated signaling. Additionally we are shipping PML-RARA Regulated Adaptor Molecule 1 Proteins (4) and PML-RARA Regulated Adaptor Molecule 1 Kits (2) and many more products for this protein.

list all antibodies Gene Name GeneID UniProt
PRAM1 378460 Q6BCL1
PRAM1 84106 Q96QH2
PRAM1 362848  
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online
  • orders@antibodies-online.com

Top anti-PML-RARA Regulated Adaptor Molecule 1 Antibodies at antibodies-online.com

Showing 10 out of 36 products:

Catalog No. Reactivity Host Conjugate Application Images Quantity Supplier Delivery Price Details
Human Goat Un-conjugated WB 0.1 mg Log in to see 6 to 8 Days
$379.50
Details
Human Goat Un-conjugated ELISA, WB ABIN184622 staining (2µg/ml) of Jurkat lysate (RIPA buffer, 30µg total protein per lane). Primary incubated for 12 hour. Detected by western blot using chemiluminescence. 100 μg Log in to see 4 to 5 Days
$318.20
Details
Human Goat Un-conjugated ELISA, WB 0.1 mg Log in to see 2 to 3 Days
$433.13
Details
Human Rabbit Un-conjugated IF (p), IHC (p), WB Formalin-fixed and paraffin embedded human kidney labeled with Anti-PRAM1 Polyclonal Antibody, Unconjugated  at 1:200 followed by conjugation to the secondary antibody and DAB staining. 100 μL Log in to see 14 to 21 Days
$269.50
Details
Human Mouse Un-conjugated IF, WB Western Blot analysis of PRAM1 expression in transfected 293T cell line by PRAM1 MaxPab polyclonal antibody.Lane 1: PRAM1 transfected lysate(73.7 KDa).Lane 2: Non-transfected lysate. Immunofluorescence of purified MaxPab antibody to PRAM1 on HepG2 cell. [antibody concentration 10 ug/ml] 50 μL Log in to see 9 Days
$430.00
Details
Human Goat Alkaline Phosphatase (AP) ELISA, WB   100 μL Log in to see 16 Days
$713.43
Details
Human Goat APC ELISA, WB   100 μL Log in to see 16 Days
$713.43
Details
Human Goat FITC ELISA, WB   100 μL Log in to see 16 Days
$713.43
Details
Human Goat Biotin ELISA, WB   100 μL Log in to see 16 Days
$713.43
Details
Human Goat PE ELISA, WB   100 μL Log in to see 16 Days
$713.43
Details

PRAM1 Antibodies by Reactivity, Application, Clonality and Conjugate

Attributes Applications Host Clonality Conjugate
Mouse (Murine) ,


, , , , , , , , , , ,
Human ,
, ,

, , , , , , , , , , , , , ,
Rat (Rattus) ,


, , , , , , , , , , ,

Top referenced anti-PML-RARA Regulated Adaptor Molecule 1 Antibodies

  1. Human Polyclonal PRAM1 Primary Antibody for WB - ABIN374107 : Moog-Lutz, Peterson, Lutz, Eliason, Cavé-Riant, Singer, Di Gioia, Dmowski, Kamens, Cayre, Koretzky: PRAM-1 is a novel adaptor protein regulated by retinoic acid (RA) and promyelocytic leukemia (PML)-RA receptor alpha in acute promyelocytic leukemia cells. in The Journal of biological chemistry 2001 (PubMed)

More Antibodies against PML-RARA Regulated Adaptor Molecule 1 Interaction Partners

Mouse (Murine) PML-RARA Regulated Adaptor Molecule 1 (PRAM1) interaction partners

  1. A yopH mutant survived better in the absence of neutrophils, indicating that neutrophil inactivation by YopH by targeting PRAM-1/SKAP-HOM (show SKAP2 Antibodies) and SLP-76 (show LCP2 Antibodies)/Vav (show VAV1 Antibodies)/PLCgamma2 (show PLCG2 Antibodies) signaling hubs may be critical for Yersinia survival.

  2. autophagy contributes to the anti-apoptotic function of the PML (show PML Antibodies)-RARalpha (show RARA Antibodies) protein through inhibiting the Akt (show AKT1 Antibodies)/mTOR (show FRAP1 Antibodies) pathway

  3. Transgenic mice expressing PML-RAR alpha (show RARA Antibodies) develop acute promyelocytic leukemia (show PML Antibodies) with long latency, low penetrance, and acquired cytogenetic abnormalities.

Human PML-RARA Regulated Adaptor Molecule 1 (PRAM1) interaction partners

  1. Our results show that the pretreatment PML (show PML Antibodies)-RARA (show RARA Antibodies) molecular burden could therefore be used to improve risk stratification in order to develop more individualized treatment regimens for high-risk APL (show FASL Antibodies) cases.

  2. The 3-plex RT-qPCR assay is a specific, sensitive, stable, and cost-effective method that can be used for the rapid diagnosis and treatment monitoring of acute promyelocytic leukemia (show PML Antibodies) with PML (show PML Antibodies)-RARa (show RARA Antibodies)

  3. The MIR125B1-mediated blockade of PML (show PML Antibodies)-RARA (show RARA Antibodies) proteolysis was regulated via an autophagy-lysosomal pathway, contributing to the inhibition of acute promyelocytic leukemia (show PML Antibodies) differentiation.

  4. autophagy contributes to the anti-apoptotic function of the PML (show PML Antibodies)-RARalpha (show RARA Antibodies) protein through inhibiting the Akt (show AKT1 Antibodies)/mTOR (show FRAP1 Antibodies) pathway

  5. PRAM-1 is required for optimal integrin-dependent neutrophil function.

  6. Caspase 3 (show CASP3 Antibodies)-cleaved SH3 domain (show ITSN1 Antibodies) of HIP-55 (show DBNL Antibodies) is likely involved in PRAM-1-mediated JNK (show MAPK8 Antibodies) activation upon arsenic trioxide-induced differentiation of NB4 cells.

  7. The use of reverse-transcription polymerase chain reaction for the detection of the PML (show PML Antibodies)-RARA (show RARA Antibodies) and RARA (show RARA Antibodies)-PML (show PML Antibodies) fusion genes that allow for monitoring of acute myelocytic leukemia.

  8. PML (show PML Antibodies)-RARalpha (show RARA Antibodies) fusion transcripts have been shown to be useful markers for establishing the diagnosis and for monitoring the response to treatment of acute promyelocytic leukemia (show PML Antibodies).

  9. Interaction of PRAM-1 and hSH3 domains of adhesion and degranulation promoting adapter protein (show TOLLIP Antibodies) (ADAP (show FYB Antibodies)) with phosphatidylcholine (show SGMS2 Antibodies)-containing liposomes is observed upon incorporation of phosphatidylserine or phosphoinositides into the membrane bilayer.

  10. hidden abnormalities and novel disease-related genomic changes occur in t(15;17)translocation in acute promyelocytic leukemia (show PML Antibodies) formation of PML (show PML Antibodies)-RARA (show RARA Antibodies) gene

PML-RARA Regulated Adaptor Molecule 1 (PRAM1) Antigen Profile

Protein Summary

The protein encoded by this gene is similar to FYN binding protein (FYB/SLAP-130), an adaptor protein involved in T cell receptor mediated signaling. This gene is expressed and regulated during normal myelopoiesis. The expression of this gene is induced by retinoic acid and is inhibited by the expression of PML-RARalpha, a fusion protein of promyelocytic leukemia (PML) and the retinoic acid receptor-alpha (RARalpha).

Gene names and symbols associated with PRAM1

  • PML-RARA regulated adaptor molecule 1 (PRAM1) antibody
  • PML-RAR alpha-regulated adaptor molecule 1 (Pram1) antibody
  • PML-RARA regulated adaptor molecule 1 (Pram1) antibody
  • AY665714 antibody
  • PML-RAR antibody
  • PRAM-1 antibody
  • PRAM1 antibody
  • RGD1564330 antibody

Protein level used designations for PRAM1

PML-RARA regulated adaptor molecule 1 , PML-RARA-regulated adapter molecule 1-like , PML-RARA-regulated adapter molecule 1 , PRAM-1 , PML-RARA target gene encoding an Adaptor Molecule-1 , PRAM , PML-RAR alpha-regulated adaptor molecule 1

GENE ID SPECIES
420067 Gallus gallus
455672 Pan troglodytes
504848 Bos taurus
611630 Canis lupus familiaris
100057936 Equus caballus
100388175 Callithrix jacchus
100514337 Sus scrofa
378460 Mus musculus
84106 Homo sapiens
362848 Rattus norvegicus
Selected quality suppliers for anti-PML-RARA Regulated Adaptor Molecule 1 (PRAM1) Antibodies
Did you look for something else?